RNASE1 and neoplasm: The discrepancy may mainly come from tumor or cell-type specificity because HT-29 cells, unlike 4T1 cells, express low or undetectable levels of EphA4 64, thus stopping RNase1 from binding to and activating EphA4 signaling in HT-29 cells.